COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 797: Articles 7961-7970  | Next

Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody
Kumar, S., Patel, A., Lai, L., Chakravarthy, C., Valanparambil, R., Davis-Gardner, M. E., Edara, V. V., Linderman, S., Reddy, E. S., Gottimukkala, K., Nayak, K., Bajpai, P., Singh, V., Frank, F., Cheedarla, N., Verkerke, H., Neish, A. S., Roback, J. D., Mantus, G., Goel, P. K., Rahi, M., Davis, C. W., Wrammert, J., Suthar, M. S., Ahmed, R., Ortlund, E., Sharma, A., Krishna, K. M., Chandele, A.
10.1101/2022.05.13.491770 — Posted: 2022-05-13
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
Wang, Z., Muecksch, F., Muenn, F., Cho, A., Zong, S., Raspe, R., Ramos, V., Johnson, B., Tanfous, T. B., DaSilva, J., Bednarski, E., Guzman-Cardozo, C., Tober-Lau, P., Hillus, D., Yao, K., Shimeliovich, I., Turroja, M., Millard, K. G., Dizon, J., Kaczynska, A., Gazumyan, A., Jankovic, M., Oliveira, T. Y., Caskey, M., Bieniasz, P. D., Hatziioannou, T., Kurth, F., Sander, L., Nussenzweig, M. C., Gaebler, C.
10.1101/2022.05.13.491823 — Posted: 2022-05-13
Three-doses of BNT162b2 COVID-19 mRNA vaccine establishes long-lasting CD8+ T cell immunity in CLL and MDS patients
Hernandez, S. P. A., Hersby, D. S., Munk, K. K., Tamhane, T., Trubach, D., Tagliamonte, M., Buonaguro, L., Gang, A. O., Hadrup, S. R., Saini, S. K.
10.1101/2022.05.13.491706 — Posted: 2022-05-13
Optimality of Maximal-Effort Vaccination
Penn, M. J., Donnelly, C. A.
10.1101/2022.05.12.22275015 — Posted: 2022-05-13
In situ architecture and membrane fusion of SARS-CoV-2 Delta variant
Song, Y., Yao, H., Wu, N., Zhang, Z., Xu, J., Peng, C., Li, S., Kong, W., Chen, Y., Zhu, M., Wang, J., Shi, D., Zhao, C., Lu, X., Echavarria Galindo, M., Li, S.
10.1101/2022.05.13.491759 — Posted: 2022-05-13
A study protocol for a retrospective cohort study and interrupted time series analysis to assess the effect of the COVID-19 pandemic on major trauma presentations and patient outcomes in English hospitals.
Marincowitz, C., Bouamra, O., Coates, T., Kumar, D., Lockey, D., Mason, L., Newcombe, V., Thompson, J., Yates, D., Lecky, F.
10.1101/2022.05.10.22274804 — Posted: 2022-05-13
Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-COV-2 Delta Variant
Huang, K., Li, N., Li, Y., Zhu, J., Fan, Q., Yang, J., Gao, Y., Liu, Y., Hou, Q., Gao, S., Wei, K., Deng, C., Zuo, C., Sun, Z.
10.1101/2022.05.12.491597 — Posted: 2022-05-12
The SARS-CoV-2 Spike Protein Activates the Epidermal Growth Factor Receptor-Mediated Signaling
Palakkott, A., Alneyadi, A., Muhammad, K., Ali, E. H., Amiri, K., Ayoub, M. A., Iratni, R.
10.1101/2022.05.10.491351 — Posted: 2022-05-12
Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants
Wilson, I. M., Frazier, M. N., Li, J.-L. N., Randall, T. A., Stanley, R. E.
10.1101/2022.05.10.491349 — Posted: 2022-05-12
Low immune response after 1.5 years of primary SARS-CoV-2 infection and Covishield vaccination lead to SARS-CoV-2 reinfection
Shete, A. M., Patil, D. Y., Sahay, R. R., Sapkal, G. N., Deshpande, G. R., Yadav, P.
10.1101/2022.05.12.491584 — Posted: 2022-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).